Journament

Keyword Connections - hepatic steatosis Keywords

Connection Type	Connection
Journals	Marine drugs The Science of the total environment Hepatology The American journal of Chinese medicine
Research Groups	No Research Group Connected
Bibliographies	[1] Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway. [2] Contamination of organohalogen chemicals and hepatic steatosis in common kingfisher (Alcedo atthis) breeding at a nature reserve near e-waste recycling sites in South China. [3] the state of pancreatobiliary system and intestinal microflora in children with nonalcoholic fatty liver disease [4] effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat [5] cholelithiasis in obese adolescents treated at an outpatient clinic [6] rho, a fraction from rhodiola crenulate, ameliorates hepatic steatosis in mice models [7] increased susceptibility of post-weaning rats on high-fat diet to metabolic syndrome [8] Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model. [9] Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial. [10] Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice [11] Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy. [12] Reply to "The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor". [13] Whole Grain Consumption and Its Effects on Hepatic Steatosis and Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. [14] Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population [15] Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes. [16] Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling. [17] Contamination of organohalogen chemicals and hepatic steatosis in common kingfisher (Alcedo atthis) breeding at a nature reserve near e-waste recycling sites in South China. [18] trif differentially regulates hepatic steatosis and inflammation/fibrosis in micesummary [19] effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat [20] efficacy of acetylshikonin in preventing obesity and hepatic steatosis in db/db mice [21] pnpla3 rs1010023 predisposes chronic hepatitis b to hepatic steatosis but improves insulin resistance and glucose metabolism [22] rho, a fraction from rhodiola crenulate, ameliorates hepatic steatosis in mice models [23] the korean mistletoe (viscum album coloratum) extract has an antiobesity effect and protects against hepatic steatosis in mice with high-fat diet-induced obesity [24] inflammatory mediators of hepatic steatosis [25] zinc oxide nanoparticle caused plasma metabolomic perturbations correlate with hepatic steatosis [26] obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated c-reactive protein and hepatic steatosis in a large healthy brazilian population [27] effect of dietary cocoa tea (camellia ptilophylla) supplementation on high-fat diet-induced obesity, hepatic steatosis, and hyperlipidemia in mice [28] pparα is required for pparδ action in regulation of body weight and hepatic steatosis in mice [29] nuciferine downregulates per-arnt-sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in hepg2 cells [30] treatment with lobeglitazone attenuates hepatic steatosis in diet-induced obese mice [31] Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model.